Results demonstrate how implementing adjusted procedures to limit radiation exposures for children may lower cancer risks and save on health care costs.
Signify Research shares the latest big trends in cardiovascular IT systems, including the role of EMR cardiology modules vs. third-party CVIS, structured reporting, integration into enterprise imaging and inclusion of ambulatory surgical centers.
A comparison of cortical thickness between the brains of obese patients to those with Alzheimer’s disease. Darker colors indicate similarities in cortical thickness between the two groups.
CREDIT: Filip Morys
New data suggest that both obesity and Alzheimer's can cause excess grey matter cortical thinning.
Example of various breast MRI protocol sequences that offer different types of soft tissue enhancement. Breast MRI can help see through dense breast tissue to better detect cancers. Imaging performed on a Siemens Magnetom system.
The modality outperformed digital breast tomosynthesis, handheld ultrasound and automated breast ultrasound for cancer detection in a large cohort of women with dense breast tissue.
The Nanox ARC cold-cathode, tomosythesis 3D X-ray system is currently pending FDA clearance. If cleared, it would be the first device of its kind to offer cold-cathode X-ray tube technology and the ability to slice through the anatomy in images similar to CT scans. The new tube type also could greatly reduce the size and weight of X-ray systems. The vendor sees this system as key to its larger plan to address health disparities and access to imaging worldwide.
Bhvita Jani, research manager at Signify Research, explains advances in cold-cathode X-ray tube technology and how this might represent a major shift in radiology imaging systems.
The Society of Radiographers recently indicated that many students had approached them about discriminatory practices occurring during their clinical training.
In March of 2022, 177Lu-PSMA-617 was approved by the U.S. Food and Drug Administration for the treatment of metastatic castration-resistant prostate cancer in men with PSMA-avid disease who have previously undergone chemotherapy and a novel androgen receptor-directed therapy.
